HealthEquity (HQY) Q2 2027 Earnings Call Transcript

HealthEquity reported Q2 revenue of $350.7M (+8% YoY) and record adjusted EBITDA of $167.0M (+11% YoY) with a record 48% margin. The company raised FY2027 guidance to $1.411B–$1.421B revenue and $628M–$636M adjusted EBITDA, supported by HSA assets of $37.9B (+14% YoY) and operating cash flow of $136.0M. It also repurchased $108.1M of shares (1.2M shares at an average price below $90), while AI-enabled automation drove 85% of routine chat inquiries and reduced human-handled service calls by 25% YoY.

Analysis

HQY is increasingly a margin-quality story rather than a pure rates story. The market should care less about headline custodial yield and more about the company proving it can compound members, reduce servicing cost per account, and keep pricing discipline despite a competitive benefits-admin backdrop. That combination is what supports a higher multiple: if fixed-service costs keep falling while account growth stays healthy, the earnings stream starts to look more software-like than sweep-rate-like.

The second-order winner is the integrated platform model. As members move from dormant balances to investing and transacting, HQY may sacrifice some near-term cash balances, but it increases lifetime value and lowers churn; that should pressure less integrated HSA/CDB administrators and smaller benefit platforms that lack a sticky app layer. The loser is any competitor forced to discount admin fees without a comparable automation stack, because HQY can share less savings back to clients over time if its cost curve keeps dropping.

The contrarian point is that the street may be over-anchored to the yield line and under-anchored to the hedge book. Near-term upside from higher Treasury yields is partly capped, so the cleaner catalyst is proving that AI-driven service savings and app engagement can offset price erosion. If open-enrollment metrics or client renewals show concessions outpacing automation, the current thesis can unwind quickly; if not, the setup looks constructive for a 1-3 month rerate and a longer 6-18 month compounding story.

Key Decisions for Investors

• Buy HQY on any post-earnings consolidation or 5-7% pullback; the next 1-3 month upside should come from multiple expansion if investors accept that margins are structurally higher, not just rate-driven.
• Pair trade: long HQY / short WEX for the next 1-2 quarters. HQY has the cleaner operating-leverage story, while WEX is more exposed to competitive pricing and less visible monetization of member engagement.
• Do not chase HQY as a Treasury beta trade. Use any move higher in 5Y yields as a chance to add only if service revenue and active-user metrics remain intact; the hedge book limits the direct rate pass-through.
• Set a downside alert if service revenue growth decelerates sharply or if management signals admin-fee concessions are materially exceeding cost savings; that would falsify the margin-expansion thesis.
• For risk-taking accounts, consider a 6-month call structure on HQY after implied volatility cools; the catalyst path is next app rollout plus open-enrollment data, not the quarter just reported.